Modawake 200mg (Modafinil Tablets)

Description

What Is Modawake?

Modawake 200mg is presented as a branded product labelled as containing modafinil at a 200mg strength. The clinical and safety information on this page primarily concerns modafinil as the active pharmaceutical ingredient and should not be interpreted as evidence that the exact Modawake finished product is ARTG registered or has Australian-approved indications.

Available trademark information associates the MODAWAKE name with HAB Pharmaceuticals & Research Ltd. This association does not independently establish the current manufacturer, manufacturing site, formulation, composition or regulatory status of the exact finished product.

Because excessive daytime sleepiness can have different underlying causes, treatment with modafinil should follow an appropriate clinical assessment of the patient’s symptoms, medical history and other medicines.

The Neuroscience Behind Modafinil

The wakefulness-related effects associated with Modawake 200mg are attributed to its labelled active ingredient, modafinil. The precise mechanism of modafinil remains incompletely understood, but research indicates that it affects several neural and neurotransmitter systems involved in maintaining wakefulness.

Dopaminergic signalling appears to play a role, while other neural systems may also contribute to modafinil’s overall effects. These mechanisms are complex and should not be reduced to a single pathway or interpreted as evidence that modafinil is free from stimulant-related or other medicine risks.

There is no single verified Modawake-specific onset time. Absorption and pharmacokinetic timing, the first perceived change in alertness, duration of wakefulness-related effects and longer-term clinical response are separate concepts.

For broader educational context about timing involving a separate branded modafinil product, see how long Modvigil 200mg takes to work. That article should not be treated as Modawake-specific onset evidence or as evidence of identical pharmacokinetics or bioequivalence.

Recognised Medical Uses

Modafinil is used in recognised medical settings involving excessive daytime sleepiness, including narcolepsy, obstructive sleep apnoea where appropriate primary treatment remains important, and shift work sleep disorder in appropriately selected patients.

For obstructive sleep apnoea, wakefulness-promoting treatment addresses excessive sleepiness rather than the underlying airway obstruction. Appropriate primary treatment, including CPAP where prescribed or recommended, should continue.

These treatment contexts relate to modafinil and relevant clinical or registered-product evidence. They do not establish Australian-approved indications for Modawake 200mg.

For broader ingredient-level educational context, see Modvigil 200mg uses, benefits and side effects.

Modafinil and Shift-Work Timing

Clinical evidence concerning modafinil in shift work sleep disorder includes treatment timed in relation to the work period. This evidence relates to modafinil studied in that clinical context and should not be interpreted as Modawake-specific administration instructions or proof of an Australian-approved Modawake shift-work regimen.

People receiving modafinil for shift-related sleepiness should follow the timing and dosing instructions provided by their prescribing healthcare professional and valid product-specific medicine information. General timing information should not replace individual medical advice.

Before Starting Treatment

Before using Modawake 200mg, patients should discuss relevant medical history with their healthcare professional. Modafinil-level safety considerations can include cardiovascular disease, high blood pressure, liver or kidney problems, significant psychiatric conditions and previous serious medicine reactions.

Healthcare professionals should also be informed about all prescription medicines, over-the-counter products and supplements being used.

Pregnancy requires particular caution. Australian regulatory information for the registered modafinil product MODAVIGIL was updated to include pregnancy in its contraindications and to strengthen information concerning fetal harm, congenital malformations and spontaneous abortion. The TGA provides updated pregnancy safety information for modafinil.

This information concerns MODAVIGIL and should not be represented as Modawake Product Information. Anyone who is pregnant, planning pregnancy or becomes pregnant while receiving modafinil should seek medical advice promptly.

People who are breastfeeding or planning to breastfeed should discuss modafinil treatment separately with their healthcare professional so that individual circumstances can be assessed.

Taking the Medicine

Modawake 200mg should only be used according to the instructions provided by the prescribing healthcare professional and valid product-specific labelling supplied with the medicine.

General administration instructions from other modafinil products should not be treated as verified Modawake directions. Dose, timing, frequency and treatment duration should be determined individually rather than inferred from the product name or general online information.

If a dose is missed, patients should follow the instructions provided by their prescriber, pharmacist or valid product-specific medicine information rather than changing the dosing schedule independently.

Possible Side Effects

Modafinil can cause side effects. Reported effects include headache, nausea, dizziness, nervousness or anxiety, difficulty sleeping and gastrointestinal symptoms. Individual experiences vary.

Serious reactions have also been reported with modafinil, including severe skin reactions, serious hypersensitivity reactions, cardiovascular symptoms and significant psychiatric or behavioural changes.

Seek prompt medical attention for serious or unexpected symptoms such as a severe or spreading rash, facial or throat swelling, difficulty breathing, chest pain, hallucinations, suicidal thoughts or marked behavioural changes.

These safety statements concern modafinil and should not be interpreted as independent Modawake-specific pharmacovigilance evidence.

For broader ingredient-level safety context, see Modvigil 200mg side effects.

Medicine Interactions

Modafinil may interact with other medicines and can affect the way some treatments are metabolised. Potentially relevant interactions include certain anticoagulants, anti-epileptic medicines, antidepressants, hormonal contraceptives and other medicines affected by liver-enzyme pathways.

The significance of an interaction depends on the medicines involved and individual clinical circumstances. Patients should provide their healthcare professional or pharmacist with a complete list of prescription medicines, over-the-counter products, vitamins, herbal products and supplements.

Hormonal Contraception

Modafinil can interact with hormonal contraception and may reduce the effectiveness of some hormonal contraceptive methods. People using hormonal contraception should obtain individual contraceptive advice from an appropriately qualified healthcare professional.

Practical Safety Advice

An underlying sleep disorder can itself impair alertness, and individual responses to modafinil treatment vary. Patients should understand how both their condition and treatment affect them before driving, operating machinery or undertaking other safety-sensitive activities.

Regular medical review remains important. New or worsening symptoms should be reported promptly, and healthcare professionals should be informed before significant treatment changes or when new medicines are introduced.

Alcohol use should be discussed with a healthcare professional rather than assuming that a specific interaction applies to every individual.

Storage

• Follow the storage instructions supplied on the product packaging or label.
• Keep the medicine in its supplied packaging where appropriate.
• Keep medicines out of sight and reach of children.
• Do not use the product after the expiry date shown on the packaging.

Exact Modawake 200mg storage conditions should be taken from valid product-specific information rather than inferred from storage requirements for another medicine.

Understanding Modawake and Modafinil

Modawake 200mg and modafinil are related terms but are not interchangeable concepts. Modawake is the branded finished product discussed on this page, while modafinil is the active pharmaceutical ingredient the product is presented as containing.

Different finished products labelled as containing modafinil may differ in formulation, excipients, packaging, manufacturing arrangements and regulatory status. A shared claimed ingredient does not establish bioequivalence, interchangeability, identical pharmacokinetics or identical clinical performance.

For broader educational context on the difference between a branded finished product and an active ingredient, see Modvigil 200mg vs Modafinil. Modvigil and Modawake remain separate branded products.

Responsible Use

Modafinil is a prescription-only medicine in Australia. This ingredient-level regulatory status does not itself establish ARTG registration or Australian-approved indications for the Modawake finished product.

Responsible use of Modawake 200mg means following professional medical advice, avoiding unauthorised dose changes, not sharing prescription medicines with others and attending recommended clinical reviews.

Wakefulness-promoting treatment should not be used as a substitute for adequate sleep or appropriate management of an underlying sleep disorder.

Frequently Asked Questions

What is Modawake 200mg used for?

Modawake 200mg is presented as a branded product labelled as containing modafinil at a 200mg strength. Modafinil has recognised clinical uses in certain conditions involving excessive daytime sleepiness, but those ingredient-level uses do not establish Australian-approved indications for the exact Modawake finished product.

Is Modawake the same as modafinil?

No. Modawake is the branded finished product discussed on this page, while modafinil is the active pharmaceutical ingredient the product is presented as containing. That distinction does not establish the exact product’s Australian registration or regulatory status.

Can older adults use modafinil?

Age can be relevant when assessing medicine treatment, but older-adult monitoring and dosing decisions should be made by the treating healthcare professional. General registered-product information should not be interpreted as Modawake-specific geriatric dosing instructions.

Can hormonal contraceptives become less effective?

Modafinil can interact with hormonal contraception. Anyone using hormonal contraception should discuss appropriate contraceptive advice with their healthcare professional rather than relying on general online guidance.

Is a prescription required in Australia?

Modafinil is a Schedule 4 Prescription Only Medicine in Australia. This scheduling status applies to modafinil and does not by itself establish ARTG registration or Australian-approved indications for Modawake.

Medical Disclaimer

This information about Modawake 200mg is provided for general educational purposes only and does not replace personalised medical advice, diagnosis or treatment. It should not be used for self-diagnosis, self-selection of a medicine or self-dosing.

Modafinil is a Schedule 4 Prescription Only Medicine in Australia. Decisions about whether modafinil treatment is appropriate, how it should be used and how treatment should be monitored require assessment by an appropriately qualified healthcare professional.

Australian clinical, prescribing and regulatory information concerning modafinil or other registered modafinil products does not establish that the Modawake finished product is ARTG registered, has Australian-approved indications or has Australian-approved Modawake-specific dosing or administration instructions.

Additional Information